POSACONAZOLE 100 mg/1 (Posaconazole TABLET, DELAYED RELEASE) 100 mg/1

Posaconazole 100 mg is an antifungal medication used to prevent and treat certain fungal infections. This delayed-release tablet is designed for oral administration and is manufactured by Lannett Company Inc.

Strength

100 mg/1

Pack Size

1000 TABLET, DELAYED RELEASE in 1 BOTTLE (0527-2133-43)

Manufacturer / TM Owner

Lannett Company Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Posaconazole is primarily used to prevent and treat fungal infections in individuals with weakened immune systems. It is often prescribed for patients undergoing chemotherapy or those with conditions that make them more susceptible to fungal infections. The medication works by stopping the growth of fungi, helping to manage and control infections effectively.

Side Effects

Common effects of Posaconazole may include gastrointestinal discomfort, such as nausea or diarrhea. Some individuals might experience headaches or changes in liver function tests. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

Posaconazole should be handled with care, especially for individuals with liver disease or those taking other medications. It is crucial to follow the prescribed dosage and administration instructions. The delayed-release tablets should be taken with food to enhance absorption.

Avoid Interactions

Posaconazole may interact with other medications, particularly those metabolized by the liver. It is important to inform healthcare providers about all current medications, including over-the-counter drugs and supplements. Alcohol should be avoided as it can affect the efficacy of the medication.

Frequently Asked Questions

Posaconazole is used to prevent and treat fungal infections in individuals with weakened immune systems.

Posaconazole delayed-release tablets should be taken orally with food to enhance absorption.

Common side effects may include gastrointestinal discomfort, nausea, diarrhea, headaches, and changes in liver function tests.

Posaconazole may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Posaconazole should be used with caution in individuals with liver disease, and a healthcare provider should be consulted before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.